LM 5 mg (Tablet)
Unit Price: ৳ 9.00 (3 x 10: ৳ 270.00)
Strip Price: ৳ 90.00
Medicine Details
Category | Details |
---|---|
Generic | Levamlodipine maleate |
Company | Acme laboratories ltd |
Also available as | Lm 25 mg tablet |
Therapeutic Class
- Calcium-channel blockers
Indications
- Treatment of hypertension
- Lowering blood pressure
- Reducing risk of cardiovascular events
Mode of Action
- Dihydropyridine calcium antagonist
- Inhibits transmembrane influx of calcium ions
- Selective effect on vascular smooth muscle cells
- Pharmacologically active isomer: Levamlodipine
Dosage & Administration
- Oral route of administration
- Usual initial dose: 2.5 mg once daily
- Maximum dose: 5 mg once daily
- Elderly and hepatically impaired patients: 1.25 mg once daily
- Pediatric dose: 1.25-2.5 mg once daily
Interaction
- Impact of CYP3A inhibitors on amlodipine
- Impact of amlodipine on simvastatin
- Impact of amlodipine on immunosuppressants
- Can be taken with or without food
- Avoid grapefruit products & natural licorice
Contraindications
- Known sensitivity to amlodipine
Side Effects
- Common: Difficulty in breathing, Dizziness, Reflex Tachycardia, Hypotension, Abdominal Pain, Edema
- Rare: Diarrhea, Back pain, Headache, Fatigue, Nausea
Pregnancy & Lactation
- Limited data on use in pregnant women
- No adverse effects observed on breastfed infants
Precautions & Warnings
- Possible symptomatic hypotension
- Risk of increased angina or myocardial infarction
- Slow titration for hepatically impaired patients
Overdose Effects
- Excessive peripheral vasodilation
- Marked hypotension
- Possibly reflex tachycardia
Storage Conditions
- Cool & dry place
- Protection from light & moisture
- Keep out of reach of children
Absorption
- Tmax: 6-12 h
- Bioavailability: 64-90%
- Not significantly affected by food
Distribution
- Volume of distribution similar to amlodipine
- Amlodipine volume of distribution: 21 L/kg
Metabolism and Excretion
- 90% metabolized to inactive metabolites
- Primarily metabolized by CYP3A4
- 60% eliminated in urine
Route of Administration
- Oral
Hypotension
- Symptomatic hypotension possible
Obstructive Coronary Artery Disease
- Increased risk of worsening angina or myocardial infarction
Liver Metabolism
- Extensively metabolized by the liver
- Plasma elimination half-life: 56 hours in hepatically impaired patients
Overdose
- Excessive vasodilation
- Marked hypotension
- Reflex tachycardia